Correlation Engine 2.0
Clear Search sequence regions


We have previously shown that N-n-butyl haloperidol iodide (F(2)), a newly synthesized compound, reduces ischemia/reperfusion (I/R) injury by preventing intracellular Ca(2+) overload through inhibiting L-type calcium channels and outward current of Na(+)/Ca(2+) exchanger. This study was to investigate the effects of F(2) on activity and protein expression of the rat myocardial sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) during I/R to discover other molecular mechanisms by which F(2) maintains intracellular Ca(2+) homeostasis. In an in vivo rat model of myocardial I/R achieved by occluding coronary artery for 30-60 min followed by 0-120 min reperfusion, treatment with F(2) (0.25, 0.5, 1, 2 and 4 mg/kg, respectively) dose-dependently inhibited the I/R-induced decrease in SERCA activity. However, neither different durations of I/R nor different doses of F(2) altered the expression levels of myocardial SERCA2a protein. These results indicate that F(2) exerts cardioprotective effects against I/R injury by inhibiting I/R-mediated decrease in SERCA activity by a mechanism independent of SERCA2a protein levels modulation. Copyright © 2012 Elsevier Inc. All rights reserved.

Citation

Yan-Mei Zhang, Chun-Yan Wang, Fu-Chun Zheng, Fen-Fei Gao, Yi-Cun Chen, Zhan-Qin Huang, Zheng-Yuan Xia, Michael G Irwin, Wei-Qiu Li, Xing-Ping Liu, Yan-Shan Zheng, Han Xu, Gang-Gang Shi. Effects of N-n-butyl haloperidol iodide on the rat myocardial sarcoplasmic reticulum Ca(2+)-ATPase during ischemia/reperfusion. Biochemical and biophysical research communications. 2012 Aug 24;425(2):426-30

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22846577

View Full Text